B.S., University of Wisconsin, La Crosse , Wisconsin, 2000
Select Honors and Awards:
Acceptance into the UC Davis Mentored Clinical Research Training Program., 2013
First place award for poster at "Medical Student Research and Poster Forum" at UC-Davis Medical Center, Symposium, 2009
American Society of Hematology Travel Award for abstract poster presentation at ASH conference, 2008
Select Recent Publications:
Kalomoiris S, Lawson J, Chen RX, Bauer G, Nolta JA, and Anderson JS. CD25 preselective anti-HIV vectors for improved HIV gene therapy. Human Gene Therapy Methods, 2012;23: 366-375.
Anderson JS and Bauer G. Fighting HIV with stem cell therapy: one step closer to human trials? Expert Review of Anti-Infective Therapy, 2012;10: 1071-1073.
Walker JE, Chen RX, McGee J, Nacey C, Pollard RB, Abedi M, Bauer G, Nolta JA, and Anderson JS. Generation of an HIV-1-resistant immune system with CD34(+) hematopoietic stem cells transduced with a triple-combination anti-HIV lentiviral vector. Journal of Virology, 2012;86: 5719-5729.
Kambal A, Mitchell G, Cary W, Gruenloh W, Jung Y, Kalomoiris S, Nacey C, McGee J, Lindsey M, Fury B, Bauer G, Nolta J. , Anderson J,. Generation of HIV-1 resistant and functional macrophages from hematopoietic stem cell-derived induced pluripotent stem cells. Molecular Therapy, 2011;19(3): 584-593.
Anderson J, Nolta J, and Bauer G. Pre-integration HIV-1 inhibition by a combination lentiviral vector containing a chimeric TRIM5α protein, a CCR5 shRNA, and a TAR decoy. Molecular Therapy, 2009;17: 2103-2114.
Anderson J, Walker J, Nolta J, and Bauer G. Specific Transduction of HIV-Susceptible Cells for CCR5 Knockdown and Resistance to HIV Infection: A Novel Method for Targeted Gene Therapy and Intracellular Immunization. Journal of AIDS, 2009;52(2): 152-161.
Anderson J, Akkina R,. HIV-1 restriction by a human-rhesus chimeric TRIM5alpha in CD34+ cell derived macrophages in vitro and in T cells in vivo in SCID-hu mice transplanted with human tissue. Human Gene Therapy, 2008;19: 217-228.
Anderson J, Akkina R,. Complete knockdown of CCR5 by lentiviral vector-expressed siRNAs and protection of transgenic macrophages against HIV-1 infection. Gene Therapy, 2007;17: 1287 - 1297.
Anderson J, Li MJ, Palmer B, Remling L, Li S, Yam P, Yee JK, Rossi J, Zaia J, and Akkina R. Safety and efficacy of a lentiviral vector containing three anti-HIV genes CCR5 ribozyme, tat-rev siRNA, and TAR decoy in SCID-hu mouse-derived T cells. Molecular Therapy, 2007;6: 1182 - 1188.
Anderson JS. Using TRIM5alpha as an HIV therapeutic: the alpha gene? Expert Opinion on Biological Therapy, 2013;13: 1029-1038.